Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DEXYCU® for the Treatment of Ocular Pain Associated With Cataract Surgery [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating DEXYCU for ocular pain associated with cataract surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Dexycu (dexamethasone intraocular suspension)

Snippet

Sponsor: EyePoint Pharmaceuticals, Inc. | Conditions: Cataract | Phase 3 | Status: WITHDRAWN